Covishield vaccine to be sold only after successful trial: Serum Institute

The current claims over the coronavirus vaccine, Covishield, are completely false and it will be commercialised when trials prove successful and regulatory approvals are in place, said Serum Institute of India (SII) on Sunday.

SII issued this clarification after reports in the media began appearing which claimed that Covishield- Oxford University's vaccine candidate, will be commercialised in a little over two months.

The phase three trials for the Oxford vaccine candidate are being conducted by SII in India.

"Serum Institute of India clarifies that